Sign in
Explore the registryTrack Donanemab's trials

Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease

DonanemabOngoingRecruitingPhase 3Open NCT07571161 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07571161 · Trial Tracker · ComplyRx